Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial
Yan‐Ping Mao(Sun Yat-sen University), Jun Ma(Shanghai Institute of Technology), Yu‐Pei Chen(Sun Yat-sen University), Li Lin(Sun Yat-sen University), Tian-Sheng Gao(Wuzhou Red Cross Hospital), Yongjie Li(University of Macau), Guan‐Qun Zhou(Sun Yat-sen University), Yuan Zhang(Sun Yat-sen University), Xiaoyu Liang(Sun Yat-sen University), Shunxin Wang(Shandong University), Ying Sun(Key Laboratory of Guangdong Province), Ling‐Long Tang(Sun Yat-sen University), Cheng Xu(Sun Yat-sen University), Xu Liu(Sun Yat-sen University), Lei Chen(Zhuzhou Central Hospital), Ning Zhang(First People's Hospital of Foshan), Lizhi Liu(Sun Yat-sen University), Rui Guo(Sun Yat-sen University), Jia‐Wei Lv(Sun Yat-sen University), Shaoqiang Liang(First People's Hospital of Foshan), Fang‐Yun Xie(Sun Yat-sen University), Wen‐Fei Li(Sun Yat-sen University), Jibin Li(State Key Laboratory of Pollution Control and Resource Reuse)
Cited by 42
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
A Metagenomic Approach to Characterization of the Vaginal Microbiome Signature in Pregnancy
|PLoS ONE|2012|703